Description

Join the 8th Blockchain International Scientific Conference ISC2026, scheduled on 27th March 2026, in London, UK. This event brings together the main researchers, scholars, policymakers, and blockchain professionals to provide and speak about peer-reviewed research on blockchain and distributed ledger technology, fostering rigorous medical communication and innovation. The convention functions a double-blind peer evaluation technique for abstracts and full papers, and is supported by way of an outstanding clinical advisory committee chaired by way of Professor Dr Naseem Naqvi MBE. ISC serves as a key platform for advancing proof-primarily based blockchain technology, connecting international idea leaders, and shaping the future of blockchain studies and practice.   Organized By The British Blockchain Association is a not-for-profit industry body established in 2017 that promotes evidence-based adoption of blockchain and distributed ledger technologies (DLT) globally, supports research and policy development, and connects academics, practitioners, and policymakers.   Event Highlights  Focus on academic & industry research in blockchain and DLT. Peer-reviewed abstract and full-paper submissions with scholarly presentations. Platform for thought leadership, research dialogue, and innovation insights.   Abstract Submission Process Submit abstracts to Editorial@thejbba.com Abstract length: Maximum 250 words Language: English only Must include: background, purpose, methodology, results, and conclusion Include a brief author biography with the abstract Submission deadline: 30 November 2025 (midnight GMT) Review process: Double-blind peer review by the ISC Committee Final decision: Made by the Conference Chair Notification of acceptance: By 5 December 2025 Full paper & presentation deadline: 30 December 2025 If no response by 15 December 2025, consider the submission unsuccessful High competition: 300+ abstracts submitted last year   ISC2026 is a premier platform to advance rigorous blockchain research and shape the future of evidence-based innovation.